Dehydroepiandrosterone sulfate/free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome

Sadeleştirilmiş öğe sayfası
dc.contributor.authorNadir, Ahmet
dc.contributor.authorTemizkan, Sule
dc.contributor.authorOzderya, Aysenur
dc.contributor.authorTemizkan, Osman
dc.contributor.authorOrbay, Ekrem
dc.contributor.authorAydin, Kadriye
dc.date.accessioned2025-10-16T15:24:15Z
dc.date.issued2019
dc.identifier.doi10.1080/09513590.2018.1505843
dc.identifier.otherWOS:000462144100009
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8084
dc.publisherTAYLOR \& FRANCIS LTD
dc.sourceGYNECOLOGICAL ENDOCRINOLOGY
dc.subjectPolycystic ovary syndrome \\(PCOS\\)
dc.subjectdehydroepiandrosterone sulfate \\(DHEAS\\)
dc.subjectfree androgen index \\(FAI\\)
dc.subjecttriglyceride \\(TG\\)
dc.subjecthigh\\-density lipoprotein cholesterol \\(HDL\\-C\\)
dc.titleDehydroepiandrosterone sulfate/free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS